510(k) · Cleared
Recalled · Class II · 2013Candela Gentlelase GL Dermatological Vascular Lesion Laser
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Candela Corp. · GEX Powered Laser Surgical Instrument
Cleared on Dec 4, 1997 as substantially equivalent to K963094 (Cynosure, Inc., 1996) after a 133-day review. Its family tree reaches back 1 generation to 1996. 1,179 later devices descend from it. It has been recalled once.
- Decided
- Dec 4, 1997
- Review
- 133 days
- Class
- Class II
- Product code
- GEX
- Recalls
- 1
- Predicates
- 1
Its longest line of descent runs back 1 generation to K963094 (1996). 1,179 later devices descend from it, 3 citing it directly.
- Root · 1 generation backK963094 Cynosure Photogenica LP Dermatological Vascular Lesion LaserCynosure, Inc. · 1996
- This deviceK972767 Candela Gentlelase GL Dermatological Vascular Lesion LaserCandela Corp. · 1997
- Descendant · cites it directly · 1,178 of its ownK974381 Candela Gentlelase GL Dermatological LaserCandela Corp. · 1998
- Descendant · 2 generations on · 1,062 of its ownK990417 DermacoolOptomed Corp. · 1999
- Descendant · 3 generations on · 1,046 of its ownK020839 Quantum, Models SR, HR, DL; Vasculight, Models SR, HR, VS, VX, DLLumenis, Inc. · 2002
- Descendant · 4 generations on · 856 of its ownK030527 Lumenis Family of Ipl and Combination Ipl/ND:Yag SystemsLumenis · 2003
- Descendant · 2 generations on · 811 of its ownK981351 Candela Gentlelase GL Dermatological LaserCandela Corp. · 1998
Showing 5 of 1,179 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 1,179 · See all- K974381Candela Gentlelase GL Dermatological LaserCandela Corp. · 1998 · cites it directly1,178descendants
- K990417DermacoolOptomed Corp. · 1999 · 2 generations on1,062descendants
- K020839Quantum, Models SR, HR, DL; Vasculight, Models SR, HR, VS, VX, DLLumenis, Inc. · 2002 · 3 generations on1,046descendants
- K030527Lumenis Family of Ipl and Combination Ipl/ND:Yag SystemsLumenis · 2003 · 4 generations on856descendants
- K981351Candela Gentlelase GL Dermatological LaserCandela Corp. · 1998 · 2 generations on811descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K963094 | Cynosure Photogenica LP Dermatological Vascular Lesion Laser | Cynosure, Inc. | 1996 | — |
| 0 (this device) | K972767 | Candela Gentlelase GL Dermatological Vascular Lesion Laser | Candela Corp. | 1997 | — |
| +1 | K974381 | Candela Gentlelase GL Dermatological Laser | Candela Corp. | 1998 | — |
| +2 | K990417 | Dermacool | Optomed Corp. | 1999 | — |
| +3 | K020839 | Quantum, Models SR, HR, DL; Vasculight, Models SR, HR, VS, VX, DL | Lumenis, Inc. | 2002 | — |
| +4 | K030527 | Lumenis Family of Ipl and Combination Ipl/ND:Yag Systems | Lumenis | 2003 | — |
| +2 | K981351 | Candela Gentlelase GL Dermatological Laser | Candela Corp. | 1998 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 4 | 0 |
| 2002 | 10 | 0 |
| 2003 | 18 | 0 |
| 2004 | 16 | 0 |
| 2005 | 22 | 0 |
| 2006 | 25 | 0 |
| 2007 | 27 | 0 |
| 2008 | 46 | 0 |
| 2009 | 31 | 0 |
| 2010 | 30 | 0 |
| 2011 | 33 | 0 |
| 2012 | 29 | 0 |
| 2013 | 42 | 0 |
| 2014 | 43 | 0 |
| 2015 | 45 | 0 |
| 2016 | 54 | 0 |
| 2017 | 56 | 0 |
| 2018 | 49 | 0 |
| 2019 | 42 | 0 |
| 2020 | 55 | 0 |
| 2021 | 50 | 0 |
| 2022 | 82 | 0 |
| 2023 | 67 | 0 |
| 2024 | 94 | 0 |
| 2025 | 128 | 0 |
| 2026 | 77 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GEX device
- #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K963094 | Cynosure Photogenica LP Dermatological Vascular Lesion LaserSummary page 1…ology) Common Name: Dermatology Laser, Longpulse Alexandrite Laser Predicate Device: Cynosure Photogenica LP Laser cleared on 10/29/96 under 510(k) notification number K963094 The Candela Gentlelase GL Lasers utilize an Alexandrite rod (crystal) which emits pulsed energy at 755 nanometers in the near in… | 1996 |
| * | — | Candela Q-Switched Alexandrite Lasers Named without a submission number |
What descends from it? (1,179)
See all 1,1793 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Nov 6, 2013 | Class II | Z-0348-2014 | Software design | Unintended single pulse maybe emitted to handpiece prior to pressing of trigger or footswitch and cause injury. |
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All GEX devicesGEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · GEX
83in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GEX
90in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GEX
3in 2024
Class I (1 since 2007) Class II/III not classified
Adverse event reports per year · GEX
2,720in 2025
MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 73 | 79 | 9 | 342 |
| 2008 | 107 | 86 | 2 | 232 |
| 2009 | 69 | 100 | 0 | 209 |
| 2010 | 50 | 96 | 4 | 1,711 |
| 2011 | 41 | 83 | 18 | 3,024 |
| 2012 | 45 | 118 | 5 | 2,000 |
| 2013 | 46 | 144 | 3 | 2,236 |
| 2014 | 61 | 147 | 6 | 2,036 |
| 2015 | 47 | 112 | 0 | 2,099 |
| 2016 | 51 | 114 | 1 | 2,585 |
| 2017 | 67 | 90 | 5 (1) | 2,977 |
| 2018 | 51 | 78 | 5 | 3,525 |
| 2019 | 41 | 88 | 6 | 2,709 |
| 2020 | 52 | 90 | 1 | 2,183 |
| 2021 | 53 | 123 | 0 | 3,465 |
| 2022 | 60 | 152 | 0 | 2,288 |
| 2023 | 52 | 87 | 6 | 2,337 |
| 2024 | 82 | 90 | 3 | 2,187 |
| 2025 | 83 | 90 | 0 | 2,720 |
| 2026 | 57 | 90 | 2 | — |
What is it indicated for?
The Candela Gentlelase GL Dermatology Vascular Lesion Laser is used for the photocoagulation of dermatological vascular lesions.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K972767 · printed Nov 6, 2026
Cite this page
510(k) Report. “K972767: Candela Gentlelase GL Dermatological Vascular Lesion Laser.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K972767
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026